Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Gilead: Hepatitis-C Access Strategy (A)
Rangan, V. Kasturi; Rangan, Vikram; Bloom, David E.Caso HBS-515025-EGilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the disease. The company had earned accolades for its work in HIV/AIDS, where its innovative medicines now accounted for 60% of all patients on Anti-Retroviral (ARV) medicines. Much of thi...Desde 8,20 €
-
Gilead: Hepatitis C Access Strategy (B)
Rangan, V. KasturiCaso HBS-515044-EWhile the Gilead: Hepatitis-C Access Strategy (A) case (515-025) poses questions on what the company should do with respect to hart hit countries like Egypt and India, this (B) case provides the answer. In both cases, the company chose to pursue a proactive strategy to enable access at affordable prices.Desde 5,74 €
-
Equitas Microfinance (C): Advent of Regulation
Narayanan, V.G.; Rangan, V. Kasturi; Muthuram, VidhyaCaso HBS-113006-ESupplement for case 510104Desde 5,74 €
-
Comergent Technologies Inc.: Enterprise E-Commerce, Teaching Note
Rangan, V. Kasturi; Bellfor, MarieNota del Instructor HBS-507087-EMarketingTeaching Note to (505-016). An abstract is not available for this product.Desde 0,00 €
-
Atlas-Copco (C): El episodio del conflicto
Rangan, V. KasturiCaso HBS-509S23MarketingDescribe la respuesta de la empresa a otros problemas con un distribuidor.Desde 5,74 €
-
Gilead: Hepatitis-C Access Strategy (A) and (B), Teaching Plan
Rangan, V. KasturiNota del Instructor HBS-520063-ETeaching plan for cases 515025 and 515044.Desde 0,00 €
-
General Electric Plastics: Organización de la Función Comercial
Rangan, V. Kasturi; Michael, Steven C.Caso HBS-505S18MarketingDescribe el rápido crecimiento de General Electric Plastics de durante la última década a un (ventas) compañía de $ 5 mil millones. Se describen las transiciones de organización de acompañamiento. La tarea es diseñar una organización de marketing para la próxima década debido a los cambios de mercado previstos.Desde 8,20 €
-
Sustainability at Siemens
Rangan, V. Kasturi; Edmondson, Amy C.; Beyersdorfer, Daniela; Moloney, EmerCaso HBS-514026-EConocimiento y comunicaciónDescribes sustainability efforts at Siemens since arrival of Chief Sustainability Officer, Barbara Kux, in 2008. Asks students to evaluate success of those efforts and outline what the company should do going forward.Desde 8,20 €
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCaso HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Desde 8,20 €
-
De Egghead a Egghead.com (A)
Rangan, V. Kasturi; Bell, MarieCaso HBS-507S15MarketingEn el transcurso de 12 meses en 1997 y 1998, Cerebrito alta dirección decidió cerrar sus 180 tiendas al por menor de ladrillo y mortero y se mueven a una tienda de electrónica. El caso describe la evolución de ese proceso, y el papel de su director general George Orban, y plantea preguntas sobre la viabilidad futura de la empresa.Desde 8,20 €